Legal Representation
Attorney
Carrie Webb Olson
USPTO Deadlines
Next Deadline
47 days remaining
Non-Final Action Mailed
Due Date
December 24, 2025
Extension Available
Until March 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 23, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 15, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 15, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 15, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable computer software for creating patient-specific virtual models for use in drug development, clinical trial simulation, and personalized medicine; downloadable computer software for physiologically based pharmacokinetic (PBPK) modeling, quantitative systems pharmacology (QSP) modeling, and predicting drug safety, efficacy, and dosing in individual patients
First Use Anywhere:
20180200
First Use in Commerce:
20180200
Class 042
Software as a service (SAAS) featuring software for creating and analyzing virtual patient models for use in drug discovery, development, and precision medicine; platform as a service (PAAS) featuring computer software platforms for physiologically based pharmacokinetic (PBPK) modeling, quantitative systems pharmacology (QSP) modeling, and simulating patient-specific drug exposure, safety, and efficacy; scientific and technological consulting services in the fields of computational modeling, biosimulation, and model-informed drug development.
First Use Anywhere:
20180200
First Use in Commerce:
20180200
Classification
International Classes
009
042